STRYKER CORP Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
STRYKER CORP (SYK) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $392.36 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-11
- STRYKER CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $392.36, a 15.50% increase from fiscal 2024.
- STRYKER CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $339.72, a 26.63% increase from fiscal 2023.
- STRYKER CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $268.28, a 8.02% increase from fiscal 2022.
- STRYKER CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $248.36, a 5.53% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $392.36 10-K · filed 2026-02-11 |
| 2024-12-31 | $339.72 10-K · filed 2025-02-12 |
| 2023-12-31 | $268.28 10-K · filed 2024-02-14 |
| 2022-12-31 | $248.36 10-K · filed 2023-02-10 |
| 2021-12-31 | $235.35 10-K · filed 2022-02-11 |
| 2020-12-31 | $216.28 10-K · filed 2021-02-11 |
| 2019-12-31 | $179.41 10-K · filed 2020-02-06 |
| 2018-12-31 | $154.50 10-K · filed 2019-02-07 |
| 2017-12-31 | $122.66 10-K · filed 2018-02-08 |
| 2016-12-31 | $96.73 10-K · filed 2017-02-09 |
| 2015-12-31 | $93.06 10-K · filed 2016-02-11 |
| 2014-12-31 | $81.13 10-K · filed 2015-02-12 |
| 2013-12-31 | $64.11 10-K · filed 2014-02-13 |
| 2012-12-31 | $53.71 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |